Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Segev Barak

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Behavioural Brain Research|April 21, 2009
Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndromeSegev Barak
International Journal of Molecular Sciences|April 30, 2021
Targeting the Reconsolidation of Licit Drug Memories to Prevent Relapse: Focus on Alcohol and NicotineSegev Barak, Koral Goltseker
Nature Reviews. Neuroscience|July 23, 2016
Molecular mechanisms underlying alcohol-drinking behavioursDorit Ron, Segev Barak
Scientific Reports|May 10, 2018
Flood-conditioned place aversion as a novel non-pharmacological aversive learning procedure in miceKoral Goltseker, Segev Barak
Psychopharmacology|February 25, 2010
Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmineSegev Barak, Ina Weiner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 15, 2010
Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuliSegev Barak, Ina Weiner
Current Topics in Behavioral Neurosciences|January 10, 2023
New Approaches for Alcohol Use Disorder Treatment via Memory Retrieval and Reconsolidation ManipulationsSegev Barak, Koral Goltseker
The International Journal of Neuropsychopharmacology|January 8, 2011
The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophreniaSegev Barak, Ina Weiner
Pharmacology, Biochemistry, and Behavior|March 23, 2011
Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive targetSegev Barak, Ina Weiner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 15, 2006
Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitorSegev Barak, Ina Weiner
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Behavioural Brain Research|April 21, 2009
Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndromeSegev Barak
International Journal of Molecular Sciences|April 30, 2021
Targeting the Reconsolidation of Licit Drug Memories to Prevent Relapse: Focus on Alcohol and NicotineSegev Barak, Koral Goltseker
Nature Reviews. Neuroscience|July 23, 2016
Molecular mechanisms underlying alcohol-drinking behavioursDorit Ron, Segev Barak
Scientific Reports|May 10, 2018
Flood-conditioned place aversion as a novel non-pharmacological aversive learning procedure in miceKoral Goltseker, Segev Barak
Psychopharmacology|February 25, 2010
Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmineSegev Barak, Ina Weiner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 15, 2010
Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuliSegev Barak, Ina Weiner
Current Topics in Behavioral Neurosciences|January 10, 2023
New Approaches for Alcohol Use Disorder Treatment via Memory Retrieval and Reconsolidation ManipulationsSegev Barak, Koral Goltseker
The International Journal of Neuropsychopharmacology|January 8, 2011
The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophreniaSegev Barak, Ina Weiner
Pharmacology, Biochemistry, and Behavior|March 23, 2011
Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive targetSegev Barak, Ina Weiner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 15, 2006
Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitorSegev Barak, Ina Weiner
Pageof 5